Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Treatment of Subclinical Rejection on Renal Histology and Graft Function in Renal Transplant Patients Receiving Tacrolimus and Mycophenolate Mofetil

NCT00885820 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00885820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00885820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Treatment of Subclinical Rejection on Renal Histology and Graft Function in Renal Transplant Patients Receiving Tacrolimus and Mycophenolate Mofetil
Lead sponsor
Astellas Pharma Inc
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2001
Completion date
January 31, 2006
Enrollment
240 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation